Dergiler / Eurasian Journal of Medical Investigation / 2020 / Cilt: 4 - Sayı: 3

Novel Coronavirus Disease ( COVID-19) Pandemic in India: A Review

Sayfa
279–283
DOI
—

Abstract

The first incidence of coronavirus disease-2019 (COVID-19) in India was disclosed on 30 January 2020. This viral pandemic disease caused by SARS-CoV-2 is a global challenge. It belong to Coronaviridiae family. The sources and mode oftransmission is similar to the previous outbreaks of coronaviruses such as MERS-CoV and SARS where the disease infection occurred due to transmission from human-to-human. The symptoms are most likely to be similar to regular cold,flu or seasonal allergies like fever, fatigue, sore throat and running nose, tiredness, and dry cough. As of 6 April, 2020 TheMinistry of Health and Family Welfare has confirmed 3851 active cases of COVID-19 infection, 318 recovered and 111deaths in India. In India, the rate of infection from COVID-19 is reported 1.7 which remarkably low as compared to otheraffected countries of the world. Initial studies suggest that COVID-19 virus may survive on the surfaces from few hoursup to several days. The treatments of patients with COVID-19 infection are basically symptomatic. Research is underwayfor the vaccine development. However, the ways to prevent virus spread by following hygiene practices such as handwashing, using masks and gloves, social distancing, etc. This article is an overview of the COVID-19 infection in India.